Antimicrobial Agents and Chemotherapy · 2020 · 30 citations · 34 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceMicrobial PathogenesisMycologyAntifungal AgentsAntifungal ResistanceAntifungal TherapyAntimicrobial Susceptibility TestingFungal InfectionsFungal PathogenesisAntifungal ChemotherapyAntifungal Drug ResistanceAntifungal Resistance MechanismsAntifungal Susceptibility TestingFungal Drug ResistanceIn Vitro Drug Susceptibility TestingNew Antifungal Agents
Lomentospora prolificans is an opportunistic fungal pathogen with low susceptibility to current antifungal drugs. Here, we tested the in vitro susceptibility of 8 drugs against 42 clinical L. prolificans isolates. All isolates showed high MICs to voriconazole (MIC 90 >16 μg/ml), itraconazole (MIC 90 >16 μg/ml), posaconazole (MIC 90 >16 μg/ml), isavuconazole (MIC 90 >16 μg/ml), amphotericin B (MIC 90 >16 μg/ml), and terbinafine (MIC 90 >64 μg/ml) and high minimum effective concentrations (MECs) to micafungin (MEC 90 >8 μg/ml), with the exception of miltefosine showing an MIC 90 value of 4 μg/ml.
34
Joseph Meletiadis, Johan W. Mouton, Jacques F. Meis et al. · Antimicrobial Agents and Chemotherapy · 2002 · 252 citations · Full text
Medicine, Microbiology, Pharmacology +17
Emilia Mellado, Guillermo García‐Effrón, Laura Alcázar‐Fuoli et al. · Antimicrobial Agents and Chemotherapy · 2004 · 207 citations · Full text
Benjamin P. Howden, Monica A. Slavin, Anthony P. Schwarer et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2003 · 198 citations